학술논문
LBO-02-Elafibranor, a peroxisome proliferator-activted receptor alpha and delta agonist demonstrates favourable efficacy and safety in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid treatment
Document Type
Abstract
Author
Source
In Journal of Hepatology April 2019 70(1) Supplement:e128-e128
Subject
Language
ISSN
0168-8278